[ad_1] [메디파나뉴스 = 조운 기자] Recently, the high concentration of fine dust in the metropolitan area has heightened the public's fear and the government is expressing concerns about its control of fine …
Read More »
[ad_1] The removal of the caecum by appendectomy reduces the risk of Parkinson's disease by 19 to 25%, according to a study. This study supports the hypothesis that the protein responsible for …
Read More »
[ad_1] Neuralstem, Inc. (Nasdaq: CUR), a biopharmaceutical company specializing in the development of new drugs for the nervous system, has published an article on the transplantation of NSI-532.IGF1 in the scientific journal …
Read More »
[ad_1] Germain Town, Maryland – (와이어) October 26, 2018 – Neuralstem, Inc. (Nasdaq: CUR), a biopharmaceutical company specializing in the development of new drugs for the treatment of the nervous system, Related …
Read More »
[ad_1] According to one study, people with low birth weight were 2.1 times more likely to have heart and cerebrovascular disease and a 2.4-fold higher risk of death than those with normal …
Read More »
[ad_1] The large-scale fall climbing is back. It's a good season for outdoor activities in the fall, especially at weekends, as many people visit the local foliage for hiking. The peak season …
Read More »
[ad_1] (Data provided = Lee Myung-soo's office) Antibiotic abuse, such as the prescription rate of 80% of prescriptions for infants and young children in national hospitals, is serious and can cause chronic …
Read More »
[ad_1] Provide correct information about liver diseases on the topic "Healthy Liver, Healthy Living". ▲ Chungbuk National University Hospital The Chungbuk National Cancer Center hosted a conference on liver disease for local …
Read More »
[ad_1] Contrast with Korea, which took a stand on bioethics Japan is pacing in the field of regenerative medicine. Approved a clinical trial of Parkinson's disease using inducible pluripotent stem cells (iPS …
Read More »
[ad_1] The Japanese government approved the Kyoto University project to request a clinical trial of Parkinson's disease using allogeneic stem cells (iPS), the Nikkei newspaper reported on June 30. According to the …
Read More »